OncRef

Clinical Trial: NCT07320521

A Study to Assess the Mass Balance of [14C]HRS-8080 in Healthy Chinese Postmenopausal Female Subjects.

Status:

COMPLETED

Phase:

Phase 1

Lead Sponsor:Shandong Suncadia Medicine Co., Ltd.
Information Provided By:Shandong Suncadia Medicine Co., Ltd.
Last Update Posted:2026-06-08

Study Overview

Brief Summary

This single-part, healthy volunteer study will try to identify how the test medicine is taken up, broken down and removed from the body. To help investigate this, the test medicine is radiolabelled, which means that the test medicine has a radioactive component (carbon-14) which helps us to track where the test medicine is in the body. The safety and tolerability of the test medicine will also be studied.

Official Title

A Phase I Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]HRS-8080 in Healthy Chinese Postmenopausal Female Subjects.

Conditions

Breast Cancer

Intervention / Treatment

  • Drug: [14C]HRS-8080

Other Study ID Numbers

  • HRS-8080-103

Start Date (Actual)

2026-01-09

Primary Completion Date (Actual)

2026-01-28

Study Completion Date (Actual)

2026-01-28

Enrollment (Actual)

6

Study Type

Interventional

Phase

Phase 1